Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Melanotan: Phase II started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

EPT started a double-blind, placebo-controlled, Australian Phase II trial in 30 patients. ......

Dermatology

Ophthalmic

Melanotan: Phase II started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

The BioCentury-BayHelix China Healthcare Summit

China Healthcare Summit

BioCentury-BayHelix East-West Summit 2027

East-West Biopharma Summit

Podcast: The BioCentury Show

Podcast: BioCentury This Week

Webinars

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Subscription

Sponsorship & Branding Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Request a Trial

Contact

Home